BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 19896224)

  • 1. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: A chemical approach to control cell fate and function.
    Li W; Jiang K; Ding S
    Stem Cells; 2012 Jan; 30(1):61-8. PubMed ID: 22028211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
    Zhang XZ
    Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules for stem cells.
    Kochegarov A
    Expert Opin Ther Pat; 2009 Mar; 19(3):275-81. PubMed ID: 19441903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemical approach to stem-cell biology and regenerative medicine.
    Xu Y; Shi Y; Ding S
    Nature; 2008 May; 453(7193):338-44. PubMed ID: 18480815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protein roadmap to pluripotency and faithful reprogramming.
    Wang J; Orkin SH
    Cells Tissues Organs; 2008; 188(1-2):23-30. PubMed ID: 18196921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering small molecules to control stem cell fate.
    Andrews PD
    Future Med Chem; 2011 Sep; 3(12):1539-49. PubMed ID: 21882946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical control of stem cell fate and developmental potential.
    Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG
    Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiation of cells: new approaches.
    Collas P
    Cytotherapy; 2007; 9(3):236-44. PubMed ID: 17464755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
    Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
    Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine?
    Ensenat-Waser R; Pellicer A; Simon C
    Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease.
    Christou YA; Moore HD; Shaw PJ; Monk PN
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):485-98. PubMed ID: 17854436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.